DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has entered a new agreement with Amwell(R) (NYSE: AMWL), a leader in digital healthcare enablement. The agreement outlines the delivery of DRIO’s cardiometabolic solution to Amwell customers, with the potential to reach more than 90 million users; availability of the platform is anticipated to begin in the second half of 2023. DarioHealth is committed to work with market-leading strategic partners to accelerate adoption of its powerful solutions, and the Amwell agreement is part of this strategic focus. “Amwell is a recognized leader in digital care delivery enablement covering 90 million lives through its substantial footprint of clients,” said DarioHealth president Rick Anderson in the press release. “We are proud to partner with them to take the Dario cardiometabolic suite to our target markets. Leveraging the power of our combined offering to enhance care and support for members, benefits everyone. This partnership fits the clear market demand for more condition solutions from less vendors and lowers the cost of delivering high value innovative digital health for buyers.”
To view the full press release, visit https://ibn.fm/ArxtL
About DarioHealth Corp.
DarioHealth Corp. is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results, and making the right thing to do the easy thing to do. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. For more information about the company, please visit www.DarioHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork
